Eko Low Ejection Fraction Tool (ELEFT) vs PMcardio

Direct competitors — feature-level head-to-head below. Comparability 85/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Powerful Medical

AI Verdict

Both Eko Low Ejection Fraction Tool (ELEFT) and PMcardio are AI-powered tools designed to aid in the detection of cardiac conditions through ECG analysis, with a specific focus on low ejection fraction. ELEFT integrates with Eko digital stethoscopes for point-of-care screening during physical exams, analyzing both ECG and heart sounds. PMcardio, on the other hand, is a broader AI platform that interprets 12-lead ECGs to assess over 50 cardiac conditions, including reduced LVEF, and offers deployment via mobile app, web, and enterprise integrations.

Choose Eko Low Ejection Fraction Tool (ELEFT) if…

Choose Eko Low Ejection Fraction Tool (ELEFT) if your primary goal is early, non-invasive screening for low ejection fraction (LVEF <= 40%) during routine physical exams. This tool is ideal for primary care physicians, family medicine, and internal medicine specialists who need a rapid (15-second) assessment of heart failure risk using a digital stethoscope, especially in settings where advanced diagnostic tools like echocardiography are not readily available. It integrates ECG and heart sound analysis to aid in identifying at-risk patients for timely referral and further evaluation.

View Eko Low Ejection Fraction Tool (ELEFT) →

Choose PMcardio if…

Choose PMcardio if you require comprehensive, expert-level ECG interpretation for over 50 cardiac conditions, including detailed detection of STEMI/OMI and reduced LVEF, with visual AI explainability. This platform is best suited for cardiologists, emergency medicine, and internal medicine specialists who need rapid, accurate diagnoses from any 12-lead ECG (even paper-form) and actionable treatment recommendations, particularly in acute settings or when a cardiologist is not immediately available. Its freemium model also makes it accessible for individual clinicians seeking advanced ECG analysis capabilities.

View PMcardio →

When choosing between Eko Low Ejection Fraction Tool (ELEFT) and PMcardio, physicians should consider their primary diagnostic focus and existing equipment. ELEFT, integrated with Eko digital stethoscopes, excels in aiding the early detection of low ejection fraction during routine physical exams by analyzing ECG and heart sound recordings. It’s designed for a proactive screening approach within a physical examination workflow, providing results in approximately 15 seconds as part of Eko’s SENSORA™ platform. This tool is particularly well-suited for clinicians who prioritize non-invasive, point-of-care screening for heart failure risk during patient encounters where a stethoscope is already in use.

In contrast, PMcardio is a broader AI platform focused on comprehensive ECG interpretation, capable of assessing over 50 cardiac conditions, including STEMI/OMI, various rhythms, and reduced LVEF. Its deployment as a mobile app, web platform, and enterprise integration offers greater flexibility for various clinical settings, from emergency medicine to internal medicine. The key practical difference lies in their input and scope: ELEFT leverages stethoscope data for a specific heart failure indicator, while PMcardio directly interprets standard ECGs for a much wider array of cardiac diagnoses. PMcardio’s freemium model also allows for initial exploration before committing to a Pro Plan.

Therefore, a physician primarily focused on integrating early heart failure risk detection into their physical exam routine, especially if already using Eko stethoscopes, would find ELEFT more aligned with their needs. Conversely, a clinician requiring rapid, expert-level interpretation of standard ECGs for a diverse range of cardiac conditions, and valuing deployment flexibility and a comprehensive diagnostic scope, would likely benefit more from PMcardio. The choice hinges on whether the priority is a targeted screening tool integrated with a physical exam or a versatile, in-depth ECG analysis platform.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Low Ejection Fraction Tool (ELEFT) PMcardio
Pricing Contact for pricing Freemium
Deployment Cloud-based software integrated with Eko digital stethoscopes. Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems
FDA Status 1 AI-estimated Pending AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

PMcardio

PMcardio offers a mobile app and web platform, allowing for broader accessibility and ease of use across different devices. Its ability to interpret any 12-lead ECG via image capture provides significant flexibility in various clinical settings. Eko's ELEFT, while integrated with its digital stethoscopes, requires specific hardware, which might limit its immediate usability for some clinicians.

Clinical Value

PMcardio

PMcardio detects over 50 cardiac conditions, including STEMI/OMI and reduced LVEF, and provides AI explainability with heatmaps, offering a more comprehensive diagnostic aid. Eko's ELEFT focuses specifically on low ejection fraction detection, which is valuable but narrower in scope compared to PMcardio's extensive diagnostic capabilities. PMcardio has also been validated in over 25 studies and is trusted by over 100,000 clinicians.

Pricing & Value

PMcardio

PMcardio offers a freemium model with 5 free ECG analyses per month, making it accessible for individual clinicians to try before committing to a paid plan. Eko's ELEFT requires contacting sales for pricing as it's part of an enterprise solution, which suggests a higher barrier to entry for individual users or smaller practices.

Enterprise Readiness

PMcardio

Both tools offer enterprise solutions with HIPAA compliance and BAA. PMcardio explicitly mentions enterprise integrations with EHR/CVIS and EMS systems, and offers custom pricing for organizations with unlimited users and ECG reports. Eko's ELEFT is part of its SENSORAu2122 platform, an enterprise solution, but PMcardio's broader deployment options and explicit integration capabilities suggest a more robust enterprise readiness.

Innovation

PMcardio

PMcardio stands out with its 'Queen of Hearts' for STEMI/OMI detection, 'LVsense' for reduced LVEF, and 'ECGxplain' for visual AI explainability with heatmaps, offering transparent and advanced diagnostic insights. While Eko's ELEFT is innovative in integrating AI with a stethoscope for early heart failure detection, PMcardio's broader range of AI-powered features and explainability gives it an edge in innovation.

Support & Docs

Tie

Both companies are likely to offer comprehensive support and documentation for their respective platforms, given their focus on healthcare professionals and regulatory compliance. However, specific details on the breadth and depth of their support and documentation were not extensively detailed in the provided information or readily available through general web searches to definitively pick a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Low Ejection Fraction Tool (ELEFT) PMcardio
Tool Name Eko Low Ejection Fraction Tool (ELEFT) PMcardio
Company Eko Health Powerful Medical
Description The Eko Low Ejection Fraction Tool (ELEFT) is an FDA-cleared AI algorithm that integrates with Eko digital stethoscopes to aid clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams. PMcardio is a CE-certified AI platform that interprets ECGs to assess over 50 cardiac conditions rapidly and accurately. Clinically validated in more than 25 studies and trusted by over 100,000 clinicians, it delivers rapid, expert-level interpretations, empowering various healthcare professionals to act with confidence at the point of care.
Regulatory Clearance FDA-cleared CE-certified
Key Features AI-powered low ejection fraction detection, Integrates with FDA-cleared Eko digital stethoscopes, Analyzes ECG and heart sound recordings, Provides results in approximately 15 seconds, Part of the SENSORAu2122 Cardiac Early Detection Platform, Cloud-based data processing and storage, Aids in early identification of heart failure risk, Non-invasive screening tool Instant AI-powered ECG interpretations, Detection of 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders), Queen of Heartsu2122 - STEMI and OMI Detection, LVsenseu2122 - Reduced LVEF Detection, ECGxplainu2122 - Visual AI Explainability with heatmaps, Core AI - Detects 36 core diagnoses (arrhythmias, conduction blocks, heart blocks, chamber hypertrophies), Automatic analysis of heart rate, axis, P wave, PR, QRS, and QT/QTc intervals, Culprit Artery AI confidence scores with 3D heart visualization
Specialties Cardiology, Family Medicine, Internal Medicine Cardiology, Emergency Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Eko Low Ejection Fraction Tool (ELEFT) and PMcardio.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Eko Low Ejection Fraction Tool (ELEFT) integrates with Eko digital stethoscopes, analyzing ECG and heart sound recordings during routine physical exams to provide results in approximately 15 seconds. PMcardio offers broader integration, connecting to existing ECG systems, EHR/CVIS, EMS systems, angiographic systems, and communication tools, and can be used via a mobile app or web platform.
ELEFT has demonstrated a sensitivity of 74.7% and specificity of 77.5% for detecting LVEF u226440% in a multi-site study. PMcardio has shown a sensitivity of 86% and specificity of 92% for major ECG abnormalities, and 97% sensitivity and 99% specificity for Atrial Fibrillation. PMcardio's Queen of Heartsu2122 model for STEMI detection has shown 92% sensitivity and 81% specificity, outperforming standard processes.
ELEFT is primarily suited for Cardiology, Family Medicine, and Internal Medicine, aiding in early heart failure detection during routine exams. PMcardio is designed for Cardiology, Emergency Medicine, and Internal Medicine, offering rapid interpretation of over 50 cardiac conditions. PMcardio aims to ease the learning curve with a guide for digitizing ECGs, focusing on matching ECG layouts and horizontal positioning.
PMcardio for Organizations is designed for enterprise-ready deployment, connecting to existing systems and scaling across campuses and care settings without custom builds. It offers unified AI models and end-to-end pathway coverage for acute care, screening, monitoring, and procedural analytics across multiple sites.
ELEFT focuses specifically on low ejection fraction detection using digital stethoscopes during physical exams, providing results in about 15 seconds. PMcardio offers a broader range of over 50 ECG findings, including STEMI/OMI detection with AI explainability heatmaps (ECGxplainu2122) and provides treatment recommendations based on ESC guidelines.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.